BBIO BridgeBio Pharma, Inc.

NASDAQ
$72.44

BridgeBio Pharma, Inc. (BBIO) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with BBIO's own trailing one-year pace, with 90% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 5 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
10
163 transactions
Purchases
$0
0 shares
Sales
$122.1M
1,739,551 shares
Net activity
-$122.1M
purchases less sales

How much of that selling was preplanned? 90% planned / 10% discretionary

10b5-1 plan sales $110.2M 157 transactions · 1,557,437 shares
Discretionary sales $11.9M 6 transactions · 182,114 shares

Largest single sale: $10.1M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Kumar Neil 3 fills Chief Executive Officer Sell 10b5-1 10,000 $84.03 $840.3K 507,586 −1.9% of holding
Kumar Neil 4 fills Chief Executive Officer Sell 10b5-1 34,980 $82.53 $2.9M 276,407 −11.2% of holding
Apuli Maricel Chief Accounting Officer Sell 10b5-1 2,000 $80.06 $160.1K 127,401 −1.5% of holding
Cook Jennifer E. 2 fills Director Sell 10b5-1 148,589 $88.54 $13.2M 120,805 −55.2% of holding
Ellis Andrea Director Sell 10b5-1 17,167 $84.00 $1.4M 22,579 −43.2% of holding
Cook Jennifer E. Director Sell 10b5-1 37,167 $70.00 $2.6M 8,383 −81.6% of holding
Cook Jennifer E. Director Sell 10b5-1 2,196 $68.57 $150.6K 8,383 −20.8% of holding
Valantine Hannah Director Sell 10b5-1 2,196 $68.57 $150.6K 9,259 −19.2% of holding
Valantine Hannah Director Sell 10b5-1 2,808 $68.00 $190.9K 11,455 −19.7% of holding
Cook Jennifer E. 2 fills Director Sell 10b5-1 90,240 $66.62 $6.0M 8,092 −91.8% of holding
Kumar Neil 6 fills Chief Executive Officer Sell 10b5-1 40,000 $67.88 $2.7M 4,331,299 −0.9% of holding
Kumar Neil 8 fills Chief Executive Officer Sell 10b5-1 40,000 $67.46 $2.7M 4,356,247 −0.9% of holding
Kumar Neil 5 fills Chief Executive Officer Sell 10b5-1 26,103 $69.44 $1.8M 267,174 −8.9% of holding
Trimarchi Thomas 2 fills President and CFO Sell 10b5-1 13,651 $65.08 $888.4K 362,389 −3.6% of holding
Scott Randal W. 4 fills Director Sell 10b5-1 10,000 $67.15 $671.5K 15,389 −39.4% of holding
Kumar Neil 6 fills Chief Executive Officer Sell 10b5-1 40,000 $66.91 $2.7M 4,364,473 −0.9% of holding
Kumar Neil 6 fills Chief Executive Officer Sell 10b5-1 40,000 $67.90 $2.7M 4,387,230 −0.9% of holding
Apuli Maricel Chief Accounting Officer Sell 10b5-1 2,000 $71.58 $143.2K 134,115 −1.5% of holding
Kumar Neil 2 fills Chief Executive Officer Sell 10b5-1 40,000 $74.60 $3.0M 4,398,447 −0.9% of holding
Kumar Neil 6 fills Chief Executive Officer Sell 10b5-1 40,000 $74.62 $3.0M 4,431,375 −0.9% of holding
Kumar Neil 4 fills Chief Executive Officer Sell 10b5-1 40,000 $68.80 $2.8M 4,448,206 −0.9% of holding
Kumar Neil 6 fills Chief Executive Officer Sell 10b5-1 40,000 $68.73 $2.7M 4,464,562 −0.9% of holding
Valantine Hannah Director Sell 10b5-1 8,671 $72.00 $624.3K 7,465 −53.7% of holding
Ellis Andrea Director Sell 10b5-1 64,921 $64.87 $4.2M 18,589 −77.7% of holding
Valantine Hannah 2 fills Director Sell 10b5-1 25,484 $67.41 $1.7M 18,365 −58.1% of holding
Apuli Maricel Chief Accounting Officer Sell 10b5-1 2,000 $66.00 $132.0K 121,945 −1.6% of holding
Kumar Neil 3 fills Chief Executive Officer Sell 10b5-1 28,053 $71.39 $2.0M 243,581 −10.3% of holding
Trimarchi Thomas 2 fills President and CFO Sell 10b5-1 13,600 $74.72 $1.0M 336,785 −3.9% of holding
Scott Randal W. 3 fills Director Sell 10b5-1 10,000 $75.46 $754.6K 19,689 −33.7% of holding
Apuli Maricel Chief Accounting Officer Sell 10b5-1 510 $74.31 $37.9K 123,945 −0.4% of holding
Kumar Neil 8 fills Chief Executive Officer Sell 10b5-1 40,000 $71.78 $2.9M 4,490,587 −0.9% of holding
Kumar Neil 4 fills Chief Executive Officer Sell 10b5-1 40,000 $71.94 $2.9M 4,504,407 −0.9% of holding
Kumar Neil 8 fills Chief Executive Officer Sell 10b5-1 40,000 $77.11 $3.1M 4,537,046 −0.9% of holding
Kumar Neil 6 fills Chief Executive Officer Sell 10b5-1 40,000 $73.97 $3.0M 4,546,882 −0.9% of holding
Kumar Neil 2 fills Chief Executive Officer Sell 10b5-1 30,011 $74.64 $2.2M 230,476 −11.5% of holding
Apuli Maricel Chief Accounting Officer Sell 10b5-1 2,000 $74.26 $148.5K 130,297 −1.5% of holding
Kumar Neil 4 fills Chief Executive Officer Sell 10b5-1 40,000 $73.31 $2.9M 4,566,159 −0.9% of holding
Kumar Neil 6 fills Chief Executive Officer Sell 10b5-1 40,000 $74.40 $3.0M 4,596,347 −0.9% of holding
Kumar Neil 3 fills Chief Executive Officer Sell 10b5-1 26,156 $65.84 $1.7M 248,531 −9.5% of holding
Lo Andrew 2 fills Director Sell 55,000 $65.69 $3.6M 81,576 −40.3% of holding
Lo Andrew 2 fills Director Sell 40,599 $66.67 $2.7M 17,887 −69.4% of holding
Trimarchi Thomas 2 fills President and CFO Sell 10b5-1 16,934 $66.46 $1.1M 389,786 −4.2% of holding
Scott Randal W. 2 fills Director Sell 10b5-1 10,000 $66.65 $666.5K 17,788 −36% of holding
Valantine Hannah Director Sell 25,484 $66.07 $1.7M 7,465 −77.3% of holding
Kumar Neil 6 fills Chief Executive Officer Sell 10b5-1 40,000 $61.42 $2.5M 4,605,955 −0.9% of holding
DANIELS RONALD J Director Sell 61,031 $63.72 $3.9M 16,991 −78.2% of holding
Kumar Neil 6 fills Chief Executive Officer Sell 10b5-1 40,000 $63.15 $2.5M 4,625,871 −0.9% of holding
MCCORMICK FRANK 5 fills Director Sell 10b5-1 198,359 $66.58 $13.2M 766,583 −20.6% of holding
MCCORMICK FRANK Director Sell 10b5-1 1,641 $65.00 $106.7K 878,338 −0.2% of holding
Kumar Neil 2 fills Chief Executive Officer Sell 10b5-1 40,000 $54.80 $2.2M 4,638,447 −0.9% of holding
Kumar Neil 4 fills Chief Executive Officer Sell 10b5-1 40,000 $54.78 $2.2M 4,669,741 −0.8% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.